These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17183731)

  • 1. Divalent metal ion coordination by residue T118 of anthrax toxin receptor 2 is not essential for protective antigen binding.
    Scobie HM; Young JA
    PLoS One; 2006 Dec; 1(1):e99. PubMed ID: 17183731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen.
    Go MY; Chow EM; Mogridge J
    Infect Immun; 2009 Jan; 77(1):52-9. PubMed ID: 18936178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrax toxin receptor 1/tumor endothelial marker 8: mutation of conserved inserted domain residues overrides cytosolic control of protective antigen binding.
    Ramey JD; Villareal VA; Ng C; Ward SC; Xiong JP; Clubb RT; Bradley KA
    Biochemistry; 2010 Aug; 49(34):7403-10. PubMed ID: 20690680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
    Scobie HM; Rainey GJ; Bradley KA; Young JA
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfide bonds in the ectodomain of anthrax toxin receptor 2 are required for the receptor-bound protective-antigen pore to function.
    Sun J; Collier RJ
    PLoS One; 2010 May; 5(5):e10553. PubMed ID: 20479891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
    Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA
    PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the interaction between anthrax toxin and its cellular receptors.
    Liu S; Leung HJ; Leppla SH
    Cell Microbiol; 2007 Apr; 9(4):977-87. PubMed ID: 17381430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of a complex between anthrax toxin and its host cell receptor.
    Santelli E; Bankston LA; Leppla SH; Liddington RC
    Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing the receptor specificity of anthrax toxin.
    Mechaly A; McCluskey AJ; Collier RJ
    mBio; 2012; 3(3):. PubMed ID: 22550037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Disulfide Bond Cys255-Cys279 in the Immunoglobulin-Like Domain of Anthrax Toxin Receptor 2 Is Required for Membrane Insertion of Anthrax Protective Antigen Pore.
    Jacquez P; Avila G; Boone K; Altiyev A; Puschhof J; Sauter R; Arigi E; Ruiz B; Peng X; Almeida I; Sherman M; Xiao C; Sun J
    PLoS One; 2015; 10(6):e0130832. PubMed ID: 26107617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of anthrax toxin to its receptor is similar to alpha integrin-ligand interactions.
    Bradley KA; Mogridge J; Jonah G; Rainey A; Batty S; Young JA
    J Biol Chem; 2003 Dec; 278(49):49342-7. PubMed ID: 14507921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.
    Chen KH; Liu S; Bankston LA; Liddington RC; Leppla SH
    J Biol Chem; 2007 Mar; 282(13):9834-9845. PubMed ID: 17251181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.
    Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ
    J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of filamentous actin to anthrax toxin receptor 1 decreases its association with protective antigen.
    Garlick KM; Batty S; Mogridge J
    Biochemistry; 2012 Feb; 51(6):1249-56. PubMed ID: 22303962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthrax toxin receptor 2 determinants that dictate the pH threshold of toxin pore formation.
    Scobie HM; Marlett JM; Rainey GJ; Lacy DB; Collier RJ; Young JA
    PLoS One; 2007 Mar; 2(3):e329. PubMed ID: 17389920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between anthrax toxin receptors and protective antigen.
    Scobie HM; Young JA
    Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protective antigen mutation increases the pH threshold of anthrax toxin receptor 2-mediated pore formation.
    Dennis MK; Mogridge J
    Biochemistry; 2014 Apr; 53(13):2166-71. PubMed ID: 24641616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of anthrax toxin pore formation.
    Gao M; Schulten K
    Biophys J; 2006 May; 90(9):3267-79. PubMed ID: 16473908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CMG2 ELISA for evaluating inhibitors of the binding of anthrax toxin protective antigen to its receptor.
    Dawson RM
    J Pharmacol Toxicol Methods; 2009; 59(1):50-5. PubMed ID: 19049885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.